Acute Progressive retro-peritoneal hematoma in COVID19 patients with sub cutaneous ecchymosis

• Published in: Annals of medicine and surgery Vol. 79; p. 104107
• Main Authors: Khalighi, Ebrahim, Marzban-Rad, Saeid, Taheri, Hamid Reza
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01-07-2022; Elsevier
• Subjects: Case Series; COVID19; Ecchymosis; Hematoma; Ecchymosis; COVID19; Hematoma
• ISSN: 2049-0801; 2049-0801
• DOI: 10.1016/j.amsu.2022.104107

and importance: COVID19 is a multifunction disease where hematological disorders are reported. Coagulopathy is seen in these patients, indicated by thromboembolic events.
We present case of 11 COVID19 who were presented with localized skin ecchymosis lesions in different areas of the body and retroperitoneal hematoma in the posterior wall of the abdomen and chest.
Increased INR and bleeding and ecchymosis in Corona patients require discontinuation of anticoagulants and, FFP, essential and tri amino injections are needed.
Diagnosis and management of hematoma is important to avoid fatality.
•Global upsurge in COVID19 cases has been marked with systemic manifestations.•We present case of 11 COVID19 who were presented with localized skin ecchymosis lesions.•We present COVID19 patients who were treated with anticoagulants and were seen to be presented with retroperitoneal hematoma.